| Denise Krenzel, | |
|
1290 Blake St, Barboursville, WV 25504-2223 | |
| (304) 634-7267 | |
| Not Available |
| Full Name | Denise Krenzel |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 1290 Blake St, Barboursville, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275142556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 24086 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Denise Krenzel, 1290 Blake St, Barboursville, WV 25504-2223 Ph: (304) 634-7267 | Denise Krenzel, 1290 Blake St, Barboursville, WV 25504-2223 Ph: (304) 634-7267 |
News Archive
A new study reveals that pediatric neuroblastoma patients are at elevated risk for long-term psychological impairment. In addition, those who experience such impairment as they get older tend to require special education services and to not go on to college.
Many drugs commonly prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma, and cardiovascular disease appear to negatively affect the aging brain causing immediate but possibly reversible cognitive impairment, including delirium, in older adults according to a clinical review now available online in the Journal of Clinical Interventions in Aging, a peer reviewed, open access publication.
300,000 American women with breast cancer might have died over the last decade, if the US had adopted a British-style, government-run health care system. This shocking figure, from recent studies by the Lewin Group and Lancet Oncology, appears in a TV ad launched today by The Independent Women's Forum, a non-profit organization focused on issues of concern for women. The 60-second spot highlights the deadly risks to women under the "public option" - or co-op - plan currently under consideration in Congress.
BioMarin Pharmaceutical Inc. today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK has completed review of the Clinical Trial Application (CTA) and issued a notice of acceptance for the Phase 3 trial of N-acetylgalactosamine 6-sulfatase (GALNS) for the treatment of Mucopolysaccharidosis IVA (MPS IVA). The company expects to initiate the Phase 3 pivotal trial early in the first quarter of 2011.
› Verified 3 days ago
Renate Birget Warden, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5 Nedra Dr, Barboursville, WV 25504 Phone: 304-916-2031 | |
Laura Elizabeth Blake, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 488 Peyton St, Barboursville, WV 25504 Phone: 304-638-9778 | |
Rebecca Dunkle, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1418 College Ave, Barboursville, WV 25504 Phone: 304-521-3029 | |
Shelby Bush, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 600 Riverview Dr, Barboursville, WV 25504 Phone: 304-360-4218 | |
Heather Leigh Miller, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6354 Us Route 60 E, Barboursville, WV 25504 Phone: 304-733-1626 Fax: 304-733-2012 | |
Jennifer Lea Hysell, RN-WTA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 6354 Us Route 60 E Ste 4, Barboursville, WV 25504 Phone: 304-733-1626 Fax: 304-733-2012 |